Verbessertes Überleben beim fortgeschrittenen oder metastasierten Prostatakarzinom durch zusätzliches Abirateron zur initialen Androgendeprivation

Cedric Oliver Carl(Universität Hamburg), Cordula Petersen(Universität Hamburg), Rudolf Schwarz(Universität Hamburg)

Strahlentherapie und Onkologie

January 4, 2018

10.1007/s00066-017-1252-4

Cited by 1

Related Papers

Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)

|Journal of Clinical Oncology|2005|654

Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression

|Journal of Clinical Oncology|2005|347

Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group

|Journal of Clinical Oncology|2003|344

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

|The Lancet Haematology|2019|329

Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients

|Journal of Clinical Oncology|2008|235